Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

MediLink Out-Licenses Novel HER3 ADC to BioNTech in $1.1 Billion Agreement

publication date: Oct 12, 2023

Suzhou MediLink Therapeutics out-licensed global rights (ex-China) for its antibody-drug conjugate candidate (against Human Epidermal Growth Factor Receptor 3 (HER3) to BioNTech in a $1.1 billion agreement. BioNTech will pay $70 million upfront to MediLink and be responsible for more than $1 billion in milestone payments. MediLink's HER3 ADC candidate has shown efficacy and safety in preclinical tumor models while early data supports its conceptual validation. Medilink is the fourth China biopharma to form a collaboration with BioNTech this year. More details....

Stock Symbol: (NSDQ: BNTX)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here